InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: None

Friday, 09/16/2016 11:22:03 PM

Friday, September 16, 2016 11:22:03 PM

Post# of 3709
I've had Palatin on my watch list for years because I am heavily invested in another company that produces the only approved and marketed melanocortin agonist, Scenesse. So far I have to say that I'm not impressed with Palatin and when it comes to their MC1R trial it is a blatant violation of the other company's patents. It's still on my watch list because of the MC4R action but I wound never consider investing until after NDA approval. If that ever happens.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News